BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2458954)

  • 21. Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes.
    Müller R; Wagner EF
    Nature; 1984 Oct 4-10; 311(5985):438-42. PubMed ID: 6541297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of the cDNAs corresponding to mRNAs abundant in undifferentiated mouse embryonal teratocarcinoma stem cells, but not in differentiated mouse parietal endoderm cells.
    Ikuma S; Kiyota M; Setoyama C; Shimada K
    J Biochem; 1986 Nov; 100(5):1185-92. PubMed ID: 2434467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased c-myc expression is an early event in retinoic acid-induced differentiation of F9 teratocarcinoma cells.
    Griep AE; DeLuca HF
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5539-43. PubMed ID: 3526333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of c-fos and AFP expression in a differentiating teratocarcinoma cell line.
    Edwards SA; Adamson ED
    Exp Cell Res; 1986 Aug; 165(2):473-80. PubMed ID: 2424777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.
    de Groot RP; Schoorlemmer J; van Genesen ST; Kruijer W
    Nucleic Acids Res; 1990 Jun; 18(11):3195-202. PubMed ID: 2113273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.
    Chan SD; Strewler GJ; King KL; Nissenson RA
    Mol Endocrinol; 1990 Apr; 4(4):638-46. PubMed ID: 2177844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutive c-myc expression enhances proliferation of differentiating F9 teratocarcinoma cells.
    Schulz WA; Gais G
    Biochim Biophys Acta; 1989 Sep; 1013(2):125-32. PubMed ID: 2475175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells.
    Rüther U; Wagner EF; Müller R
    EMBO J; 1985 Jul; 4(7):1775-81. PubMed ID: 3896777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the murine apolipoprotein E gene is coupled to the differentiated state of F9 embryonal carcinoma cells.
    Basheeruddin K; Stein P; Strickland S; Williams DL
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):709-13. PubMed ID: 3468509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P19 embryonal carcinoma cells.
    McBurney MW
    Int J Dev Biol; 1993 Mar; 37(1):135-40. PubMed ID: 8507558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
    Whitman MM; Shen YM; Soprano D; Soprano KJ
    Cancer Res; 1990 Jun; 50(11):3193-8. PubMed ID: 2139801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similarities and differences in the regulation of N-myc and c-myc genes in murine embryonal carcinoma cells.
    Sejersen T; Rahm M; Szabo G; Ingvarsson S; Sümegi J
    Exp Cell Res; 1987 Oct; 172(2):304-17. PubMed ID: 3308495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Ki-ras gene amplification and malignant behavior in murine embryonal carcinoma cell lines.
    Vilette D; Emanoil-Ravier R; Buffe D; Rimbaut C; Peries J
    Cancer Res; 1987 Feb; 47(3):867-73. PubMed ID: 3542196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular HSP90 (HSP86) mRNA level and in vitro differentiation of mouse embryonal carcinoma (F9) cells.
    Kohda T; Kondo K; Oishi M
    FEBS Lett; 1991 Sep; 290(1-2):107-10. PubMed ID: 1655528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.
    Dony C; Kessel M; Gruss P
    Nature; 1985 Oct 17-23; 317(6038):636-9. PubMed ID: 2414665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of proto-oncogenes in fundamental manifestations of life].
    Seĭts IF
    Eksp Onkol; 1990; 12(6):14-26. PubMed ID: 1702050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
    Onclercq R; Babinet C; Cremisi C
    Oncogene Res; 1989; 4(4):293-302. PubMed ID: 2671866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of c-Ki-ras2 gene expression associated with morphologic differentiation in human embryonal carcinoma cells treated with berberine.
    Chang KS
    J Formos Med Assoc; 1991 Jan; 90(1):10-4. PubMed ID: 1679102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells.
    Yang XM; Park M
    Dev Biol; 1993 Jun; 157(2):308-20. PubMed ID: 8388815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.